FindTrial
Sign In

An Integrated Model for Recurrence and BCG Responsiveness in Non-Muscle Invasive Bladder Cancer Leveraging Clinical, Imaging, and Pathological Multi-Omics Insights from a Multi-Center, Large-scale Cohort

An Integrated Model for Recurrence and BCG Responsiveness in Non-Muscle Invasive Bladder Cancer Leveraging Clinical, Imaging, and Pathological Multi-Omics Insights from a Multi-Center, Large-scale Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076043
Enrollment
Unknown
Registered
2023-09-22
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

Patients with bladder tumors:No

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients with bladder tumors undergoing TURBT surgery at participating hospitals; (2) The patient with pathological specimen after operation was diagnosed as non muscle invasive bladder cancer. (3) Patients with preoperative CT raw images.

Exclusion criteria

Exclusion criteria: (1) Poor image quality or artifacts in the scanned pathological images; (2) The clinical information data is incomplete.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Recurrence time;—

Countries

China

Contacts

Public ContactTianxin Lin

Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

lintx@mail.sysu.edu.cn+86 137 2400 8338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026